# Fibroblast Growth Factor 23 in Chronic Respiratory Failure

> **NCT05258370** · — · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Respiratory Failure

## Interventions

- **OTHER:** Dosage
- **OTHER:** Cardiac echography

## Key facts

- **NCT ID:** NCT05258370
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258370, "Fibroblast Growth Factor 23 in Chronic Respiratory Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05258370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*